Chimerix
Product Feature
CMX001 (Lipid-Antiviral-Conjugate Technology)
CMX001 combines Chimerix’s Lipid-Antiviral-Conjugate Technology with cidofovir, an approved antiviral agent, with the aim of creating a well-tolerated and highly potent new chemical entity with broad-spectrum antiviral activity. … Read More
Technology Platform
Lipid-Antiviral-Conjugate Technology
Chimerix is applying its powerful Lipid-Antiviral-Conjugate Technology to existing antiviral compounds with the goal of increasing their bioavailability,… Read More